Articles
Tasmanian feature: All in the family
Prof Terry Dwyer is the Director of the Menzies Research Institute, which he established in 1988. The institute is an epidemiology focused research organisation looking at the causes of human diseases. [ + ]
Tasmanian feature: Tasmanian Tigers
Tasmania might be the smallest Australian state, but it has some advantages for the biotechnology industry that the other states can't even dream of. [ + ]
Victorian feature: Investment Issues
Finance and funding issues affecting the biotechnology industry appear to be something of a chicken and egg scenario. [ + ]
Victorian feature: Infrastructure key to biotech success
The need to build Victoria's biotechnology infrastructure base has been recognised through the establishment of the Biotechnology Platform Technology Working Party. [ + ]
Victorian feature: Vic bio warns against early IPO
Had Amrad Corporation been conceived in the United States it would only now be considering a public listing, according to its managing director. [ + ]
Victorian feature: Smaller players face big issues
While Victorian companies who have been around the block a few times reckon the latest batch of biotech newcomers have got it relatively easy, the feeling out there is quite different. [ + ]
Victorian feature: Biotech's a real synch
One word is consistently on people's lips when discussing Victoria's biotechnology scene: hub. [ + ]
Analysing venture capital
Venture capitalists need to be as a good at analysing their clients as any psychiatrist, says Dr Mike Hirshorn, a medical doctor turned venture capitalist, now with Sydney-based VC Nanyang Ventures. [ + ]
The Mitchell viewpoint
Dr Graham Mitchell is in a unique position to comment on biotechnology in Victoria. As one of the four scientists in biotech consultancy Foursight Associates, he is one of the chief scientific advisers to the Victorian government. [ + ]
How to achieve perfect pitch
With years of experience in the business of science and training as a scientist as well as in business management, Cerylid Biosciences CEO Dr Jackie Fairley is well equipped to give advice on the pitch, whether it's in the elevator or at a venture capital forum. [ + ]
The university of bioinformatics
It used to be that biology students would run a mile from anything that smacked of computing. Now, with bio-IT touted as an indispensable element of the life sciences, what's changed? [ + ]
Proteomics Feature: How a word helped a science to take off
You can't pick up a general article about proteomics without reading somewhere in the story: "The word 'proteomics' was coined by Marc Wilkins, then a PhD student in Keith Williams' lab at Macquarie University in 1994..." [ + ]
NSW Feature: Opening NSW's BioUmbrella
The NSW government launched its BioFirst program in September last year. Like most other governments' biotech programs, the NSW initiative involves several government departments. [ + ]
NSW Feature: United they stand
Biotech in NSW doesn't appear to depend on fancy government packages, but new infrastructures are changing the face of bio in the First State. [ + ]
Bio-boards under fire
In the last month, three of Australia's most experienced listed biotechs have endured roller coaster rides on the stock market, in the case of all three because of upheaval at the board level. [ + ]